These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 9762378)

  • 1. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies for basal insulin treatment in type 2 diabetes mellitus.
    Dailey G
    Clin Ther; 2004 Jun; 26(6):889-901. PubMed ID: 15262459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive insulin regimens: evidence for benefit.
    Bretzel RG
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.
    Shogbon AO; Levy SB
    Am J Health Syst Pharm; 2010 May; 67(10):798-805. PubMed ID: 20479101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes.
    Stern MP
    Arch Fam Med; 1998; 7(2):155-62. PubMed ID: 9519921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New frontiers in the management of type 2 diabetes.
    Mudaliar S
    Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus.
    Mattila TK; de Boer A
    Drugs; 2010 Dec; 70(17):2229-45. PubMed ID: 21080740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results.
    Colwell JA
    Diabetes; 1996 Jul; 45 Suppl 3():S87-90. PubMed ID: 8674902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of glucose control.
    Edelman SV
    Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
    Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
    J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
    Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
    Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus in older patients. Is tight blood glucose control warranted?
    Lunt H
    Drugs Aging; 1996 Jun; 8(6):401-7. PubMed ID: 8736623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
    Ma J; Yang W; Fang N; Zhu W; Wei M
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes among women: clinical considerations for pharmacological management to achieve glycemic control and reduce cardiovascular risk.
    Levine JP
    J Womens Health (Larchmt); 2008 Mar; 17(2):249-60. PubMed ID: 18321176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association.
    Woolf SH; Davidson MB; Greenfield S; Bell HS; Ganiats TG; Hagen MD; Palda VA; Rizza RA; Spann SJ
    J Fam Pract; 2000 May; 49(5):453-60. PubMed ID: 10836779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.